Glucolive PG 2mg/500mg/15mg Tablet ER
Marketer
Allysia Lifesciences Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glucolive PG 2mg/500mg/15mg Tablet ER
Diabetol Trio 2mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This treatment complements diet and exercise for improved glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, reducing blood sugar. Follow your physician's prescribed dosage and regimen for Diabetol Trio. Administer with food to minimize digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling the dose. Excessive intake can cause hypoglycemia. Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Consult your doctor about pre-existing kidney, liver, or heart conditions before starting treatment. Pregnant or lactating individuals should seek medical advice. Kidney function will be assessed prior to commencing therapy. Limit alcohol consumption to mitigate potential side effects.
Uses of Glucolive PG 2mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of Glucolive PG 2mg/500mg/15mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glucolive PG 2mg/500mg/15mg Extended-Release Tablets. Ingest the tablet whole; do not break, crush, or chew it. Administer this medication with a meal.
Common Side effects of Glucolive PG 2mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glucolive PG 2mg/500mg/15mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Glucolive PG 2mg/500mg/15mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing. Consume with a meal.
How Glucolive PG 2mg/500mg/15mg Tablet ER works:
Glucolive PG 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to enhance blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glucolive PG 2mg/500mg/15mg Extended-Release tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glucolive PG 2mg/500mg/15mg tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glucolive PG tablets (2mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glucolive PG 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glucolive PG 2mg/500mg/15mg Extended-Release Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. The use of Glucolive PG 2mg/500mg/15mg Extended-Release Tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glucolive PG 2mg/500mg/15mg Tablet ER :
Should you forget a Glucolive PG 2mg/500mg/15mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glucolive PG 2mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently